Brief: Adaptive Biotechnologies Receives Expanded Medicare Coverage Of Clonoseq
28/07/2022 12:49
July 28 (Reuters) - Adaptive Biotechnologies Corp ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES RECEIVES EXPANDED MEDICARE
COVERAGE OF
CLONOSEQ® FOR MONITORING MINIMAL RESIDUAL DISEASE IN DIFFUSE
LARGE B-CELL LYMPHOMA
Source text for Eikon: ID:nGNX6Jdym3
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile